280 related articles for article (PubMed ID: 2706726)
1. The distribution and implications of BCG scars in northern Malawi.
Fine PE; Ponnighaus JM; Maine N
Bull World Health Organ; 1989; 67(1):35-42. PubMed ID: 2706726
[TBL] [Abstract][Full Text] [Related]
2. BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size.
Floyd S; Ponnighaus JM; Bliss L; Warndorff DK; Kasunga A; Mogha P; Fine PE
Int J Tuberc Lung Dis; 2000 Dec; 4(12):1133-42. PubMed ID: 11144455
[TBL] [Abstract][Full Text] [Related]
3. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification.
Pönnighaus JM; Fine PE; Sterne JA; Bliss L; Wilson RJ; Malema SS; Kileta S
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):10-23. PubMed ID: 8189075
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis prevention: where do we go from here?
Warndorff DK
Afr Health; 1996 Nov; 19(1):21-2. PubMed ID: 12291917
[TBL] [Abstract][Full Text] [Related]
7. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
[TBL] [Abstract][Full Text] [Related]
8. BCG scar and tuberculin reactivity in children and adults.
Fjällbrant H; Ridell M; Larsson LO
Scand J Infect Dis; 2008; 40(5):387-92. PubMed ID: 18418799
[TBL] [Abstract][Full Text] [Related]
9. [Where do we stand with BCG vaccination programme in Japan?].
Mori T
Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
[TBL] [Abstract][Full Text] [Related]
10. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination].
Yildirim C; Küçük AI; Ongüt G; Oğünç D; Colak D; Mutlu G
Mikrobiyol Bul; 2009 Jan; 43(1):27-35. PubMed ID: 19334377
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau.
Aaby P; Gustafson P; Roth A; Rodrigues A; Fernandes M; Sodemann M; Holmgren B; Benn CS; Garly ML; Lisse IM; Jensen H
Vaccine; 2006 Jul; 24(29-30):5718-25. PubMed ID: 16720061
[TBL] [Abstract][Full Text] [Related]
13. BCG scar survey among primary school children in Kenya (1986-1990).
Kwamanga D; Githui W; Agwanda R; Nderitu P
East Afr Med J; 1993 Sep; 70(9):568-71. PubMed ID: 8181438
[TBL] [Abstract][Full Text] [Related]
14. Cell mediated immunity in children with scar-failure following BCG vaccination.
Rani SH; Vijayalakshmi V; Sunil K; Lakshmi KA; Suman LG; Murthy KJ
Indian Pediatr; 1998 Feb; 35(2):123-7. PubMed ID: 9707854
[TBL] [Abstract][Full Text] [Related]
15. Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine.
Vallishayee RS; Anantharaman DS; Gupte MD
Indian J Lepr; 1998; 70(3):277-86. PubMed ID: 9801900
[TBL] [Abstract][Full Text] [Related]
16. Does bacille Calmette-Guérin scar size have implications for protection against tuberculosis or leprosy?
Sterne JA; Fine PE; Pönnighaus JM; Sibanda F; Munthali M; Glynn JR
Tuber Lung Dis; 1996 Apr; 77(2):117-23. PubMed ID: 8762845
[TBL] [Abstract][Full Text] [Related]
17. BCG vaccination protects against leprosy in Venezuela: a case-control study.
Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
[TBL] [Abstract][Full Text] [Related]
18. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the efficacy of two types of BCG vaccines administered in different doses].
Valenzuela MT; Ferrer X; Leal I; Pacheco M; Castillo N; Cumsille F
Rev Med Chil; 1998 Sep; 126(9):1126-31. PubMed ID: 9922519
[TBL] [Abstract][Full Text] [Related]
20. Effect of number of BCG vaccination on tuberculin induration size.
Gundogdu Z; Aydogan M; Arisoy ES; Gokalp AS
J Paediatr Child Health; 2007 Jun; 43(6):476-9. PubMed ID: 17535179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
